Parkinson's gene therapy AB-1005 trial moves forward in Europe
The first European participants in a Phase 2 trial of the Parkinson's gene therapy AB-1005 have been randomly assigned to treatment groups.| Parkinson's News Today
The first European participants in a Phase 2 trial of the Parkinson's gene therapy AB-1005 have been randomly assigned to treatment groups.| Parkinson's News Today
Xingimaging and Synusight received a MFJJ grant to develop PET imaging technology that monitors toxic protein clumps in Parkinson's.| Parkinson's News Today
The recipients of this year's grants include scientists and clinicians studying Parkinson’s biology, brain networks, and symptoms.| Parkinson's News Today
Parkinson’s patients and their care partners found several aspects of a personalized fall prevention program effective, despite barriers.| Parkinson's News Today
Seal Rock has joined an MJFF initiative to develop therapies targeting the LRRK2 gene, which can contribute to Parkinson’s development.| Parkinson's News Today
Expanding access to specialist healthcare for Parkinson's is increasingly urgent as the number of patients rise in the U.S., researchers say.| Parkinson's News Today
Analyzing real-world patient data may help researchers better understand Parkinson’s causes, its early signs, and responses to therapy.| Parkinson's News Today
ENERGI-F705PD, a potential disease-modifying therapy for Parkinson’s, was found safe and well tolerated in healthy volunteers in a trial.| Parkinson's News Today
In a mouse model of Parkinson’s, continuous exposure to low-oxygen air eased or even reversed motor symptoms and slowed disease progression.| Parkinson's News Today
Parkinson's patients receiving brain stem cell transplant therapy may be able to take a less intensive immunosuppression regimen.| Parkinson's News Today
Insilico said it plans to ask the FDA this year for permission to move an AI-designed Parkinson's therapy into clinical trials.| Parkinson's News Today
The first three Parkinson's patients who received ANPD001 saw improvements in motor symptoms and daily functioning, early trial data showed.| Parkinson's News Today
Learn about common symptoms of Rett syndrome, which can range from gradual slower development to loss of motor and communication skills to seizures.| Rett Syndrome News
Casma Therapeutics will develop CSM-101 as a potential oral treatment for Parkinson's disease and Gaucher disease.| Parkinson's News Today
Sleep disorders were mainly associated with Parkinson's motor symptoms and problems regulating involuntary bodily functions, a s tudy shows.| Parkinson's News Today
Michael S. Okun, MD, answers questions about deep brain stimulation for people with Parkinson's in our monthly "Expert Voices" series.| Parkinson's News Today
Blood levels of 2 proteins in REM sleep behavior disorder patients linked with later finding of Parkinson's-like disease, Lewy body dementia.| Parkinson's News Today
In a trial, once-daily buntanetap halted cognitive decline in early-stage Parkinson's and improved cognition in patients with mild dementia.| Parkinson's News Today
Non-motor symptoms, ranging from depression to constipation, problems sleeping to cognitive changes, can be fairly common in Parkinson's.| Parkinson's News Today
While there's no test to confirm a Parkinson's diagnosis in its early stages, the disease can be detected based on a variety of symptoms.| Parkinson's News Today
Parkinson's disease symptoms affect both motor skills and nonmotor skills, and progress differently in each person.| Parkinson's News Today
The gut microbiome of Parkinson's patients shows substantial functional differences compared with that of healthy people, per a new study.| Parkinson's News Today
A history of upper gastrointestinal mucosal damage was associated with a 76% greater risk of subsequently developing Parkinson's disease.| Parkinson's News Today
Understanding and identifying epigenetic changes in blood samples from people with Parkinson’s disease may help assess the risk of dementia.| Parkinson's News Today
Learn about Parkinson's disease, a condition that affects the brain, resulting in issues with movement, balance, and more.| Parkinson's News Today
